Chief Investment Officer

Savvas Neophytou
Savvas Neophytou
Chief Investment Officer
The world of biotech is always on the move. This year, we've seen some great progress, especially when it comes to understanding our own genes and making medicines that are tailored just for us.
Bert van der Vaart
Bert van der Vaart
Chief Investment Officer at SEAF (US)
«We have invested a lot in agriculture. Because in the emerging markets, there has been a very strong transition theme where people were moving away from a status-led economy which included a very inefficient agricultural sector, or whether issues such as climate change require technological advances to find a way to adapt to those changes. It’s all a question of transition. Unfortunately, in the agribusiness sector, you can’t do anything without understanding what the government does.»